Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gestrinone 2.5mg capsules
0607020F0AAAAAA
|
Gestrinone | Gestrinone | Endocrine System | No data available |
|
GHRH Ferring 50microgram inj ampoules
0605010ACBBAAAA
|
GHRH Ferring | Somatorelin | Endocrine System | No data available |
|
Glensoludex 4mg soluble tablets
0603020G0BGABCH
|
Glensoludex | Dexamethasone | Endocrine System | No data available |
|
Glensoludex 8mg soluble tablets
0603020G0BGACCG
|
Glensoludex | Dexamethasone | Endocrine System | No data available |
|
Glibenclamide 15mg/5ml oral liquid
0601021H0AAAMAM
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 2.5mg/5ml oral liquid
0601021H0AAAKAK
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 600micrograms/ml oral suspension sugar free
0601021H0AAAPAP
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 625micrograms/5ml oral liquid
0601021H0AAAIAI
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 6mg/ml oral suspension sugar free
0601021H0AAAQAQ
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenclamide 7.5mg/5ml oral liquid
0601021H0AAANAN
|
Glibenclamide | Glibenclamide | Endocrine System | No data available |
|
Glibenese 5mg tablets
0601021P0BBAAAB
|
Glibenese | Glipizide | Endocrine System | No data available |
|
Gliclazide 100mg/5ml oral suspension
0601021M0AAALAL
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 120mg/5ml oral suspension
0601021M0AAAIAI
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 160mg/5ml oral suspension
0601021M0AAAJAJ
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 20mg/5ml oral suspension
0601021M0AAANAN
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 30mg/5ml oral suspension
0601021M0AAAPAP
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 50mg/5ml oral suspension
0601021M0AAAHAH
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 60mg/5ml oral suspension
0601021M0AAAGAG
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Glidipion 15mg tablets
0601023B0BDACAA
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 30mg tablets
0601023B0BDAAAB
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 45mg tablets
0601023B0BDABAC
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glimepiride 2mg/5ml oral liquid
0601021A0AAAGAG
|
Glimepiride | Glimepiride | Endocrine System | No data available |
|
Glimepiride 6mg/5ml oral suspension
0601021A0AAAHAH
|
Glimepiride | Glimepiride | Endocrine System | No data available |
|
Glimil 80mg tablets
0601021M0BEAAAA
|
Glimil | Gliclazide | Endocrine System | No data available |
|
Gliquidone 30mg tablets
0601021R0AAAAAA
|
Gliquidone | Gliquidone | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.